Skip to main content
HLB PHARMACEUTICAL CO., LTD. logo

HLB PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 047920 ISIN · KR7047920004 KO Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2026-02-27 Proxy Solicitation & In…
Country KR South Korea
Listing KO 047920

About HLB PHARMACEUTICAL CO., LTD.

https://www.hlbpharma.co.kr/eng/

HLB PHARMACEUTICAL CO., LTD. is a biopharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in the production of quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices. Its portfolio also includes prescription medications like skeletal muscle relaxants. A key focus of its research and development activities is the discovery and advancement of new peptide-based drugs. As part of the broader HLB Group, it contributes to a diverse portfolio that spans pharmaceuticals, medical devices, and diagnostics.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by HLB Pharmaceutical. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation material provided to shareholders to inform them of the meeting and request their votes, which falls under the Proxy Solicitation & Information Statement category.
2026-02-27 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees/executives, including the number of shares, exercise price, and vesting conditions. Since this is a specific regulatory disclosure regarding capital/equity structure changes (stock options) and does not fit into the other specific categories like 'SHA' (which usually refers to share issuance/capital changes) or 'DIRS' (insider dealing), it is best classified as a general regulatory filing.
2026-02-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from HLB Pharmaceutical regarding a significant change in revenue or profit structure (30% or more). This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audited annual report is published. It provides key financial highlights (revenue, operating profit, net income) and explains the cause of the variance. It is not a full annual report (10-K) or an interim report (IR), but rather an earnings-related disclosure, which falls under the Earnings Release (ER) category.
2026-02-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and major contracts (such as stock collateral agreements) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-01-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from HLB Pharmaceutical regarding the setting of a record date for the purpose of holding an upcoming Annual General Meeting (AGM). It is not the AGM presentation itself, nor a proxy statement, but a formal notice of the record date for shareholder rights. Given the nature of the announcement as a regulatory disclosure regarding meeting preparation, it falls under the RNS category.
2025-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(일반)' which translates to 'Report on Large Shareholding Status (General)'. It contains detailed information about shareholdings, ownership percentages, changes in shareholdings, and related contractual details. The document references specific dates and includes data about major shareholders and their holdings. There is no indication that this is an announcement of a report publication or a certification. The content matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds as per regulatory requirements.
2025-10-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.